Vimarsana
Biggest News Aggregation in the World

Page 2 - Erick Rowinsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Erick Rowinsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Erick Rowinsky Today - Breaking & Trending Today

Investment House LLC Cuts Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Investment House LLC Cuts Stock Holdings in Biogen Inc. (NASDAQ:BIIB)

Investment House LLC lessened its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in Biogen were worth $846,000 as of its most recent SEC filing. […]

Biogen Inc. (NASDAQ:BIIB) Position Decreased by Investment House LLC - Vimarsana News

Biogen Inc. (NASDAQ:BIIB) Position Decreased by Investment House LLC

Investment House LLC reduced its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in […]

Wedbush Boosts Biogen (NASDAQ:BIIB) Price Target to $215.00 - Vimarsana News

Wedbush Boosts Biogen (NASDAQ:BIIB) Price Target to $215.00

Biogen (NASDAQ:BIIB – Free Report) had its target price upped by Wedbush from $213.00 to $215.00 in a report published on Thursday morning, Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q2 2024 earnings at $3.43 EPS, Q4 2024 earnings at $4.30 EPS, FY2024 […]

Barclays Trims Biogen (NASDAQ:BIIB) Target Price to $200.00 - Vimarsana News

Barclays Trims Biogen (NASDAQ:BIIB) Target Price to $200.00

Biogen (NASDAQ:BIIB – Free Report) had its target price trimmed by Barclays from $215.00 to $200.00 in a report published on Thursday morning, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. BIIB has been the topic of several other research reports. Wedbush upped their target price on Biogen from […]

Gitterman Wealth Management LLC Purchases New Shares in Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Gitterman Wealth Management LLC Purchases New Shares in Biogen Inc. (NASDAQ:BIIB)

Gitterman Wealth Management LLC purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 980 shares of the biotechnology company’s stock, valued at approximately $254,000. Other institutional investors have also added to or reduced […]